FOLD
NEUTRALM&AAmicus Therapeutics, Inc.
Price
$14.31
+0.07%Score12.0Top Tier
Signals5/8 DNA1/13 Act · 0/4 Risk
SentimentNEUTRALScore: 1
Volume0.6xvs 20d avg
Analysis
FOLD is currently exhibiting the structural signature of a **Merger Arbitrage** play rather than a growth breakout. The 'Quiet Storm' signal and effectively non-existent realized volatility (3.5% annualized) confirm the stock is pinned to the **$14.50/share all-cash acquisition offer from BioMarin (BMRN)** announced in December. With the stock trading at $14.31, the ~1.3% spread implies the market is pricing in a high probability of closing in Q2, though the spread is tight relative to the 4.19% risk-free rate, suggesting capital is treating this as a near-cash equivalent.
Fired Signals
ALPHA MALEQUIET STORMGOLDEN CROSSBOLLINGER SQUEEZEPERFECT STACKSELLER FATIGUE
© 2026 Signal52 • For educational purposes only